Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Price Target

Price Target

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

Stifel Upgrades CSX to Buy, Lowers Price Target to $37

By Benzinga Newsdesk
July 15, 6:08 AM
Stifel analyst Benjamin Nolan upgrades CSX (NASDAQ:CSX) from Hold to Buy and lowers the price target from $39 to $37.

CSX

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Baird Downgrades Duke Realty to Neutral, Lowers Price Target to $74

By Benzinga Newsdesk
July 15, 4:56 AM
Baird analyst David Rodgers downgrades Duke Realty (NYSE:DRE) from Outperform to Neutral and lowers the price target from $78 to $74.

DRE

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Goldman Sachs Initiates Coverage On Rover Group with Neutral Rating, Announces Price Target of $4.5

By Benzinga Newsdesk
July 15, 4:54 AM
Goldman Sachs analyst Eric Sheridan initiates coverage on Rover Group (NASDAQ:ROVR) with a Neutral rating and announces Price Target of $4.5.

ROVR

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Stephens & Co. Initiates Coverage On ACI Worldwide with Overweight Rating, Announces Price Target of $31

By Benzinga Newsdesk
July 15, 4:52 AM
Stephens & Co. analyst Charles Nabhan initiates coverage on ACI Worldwide (NASDAQ:ACIW) with a Overweight rating and announces Price Target of $31.

ACIW

Read More
1 minute read
  • Analyst Ratings
  • Cannabis
  • Markets
  • News
  • Price Target

Cantor Fitzgerald Maintains Overweight on OrganiGram Holdings, Lowers Price Target to C$2.9

By Benzinga Newsdesk
July 15, 4:47 AM
Cantor Fitzgerald analyst Pablo Zuanic maintains OrganiGram Holdings (TSX:OGI) with a Overweight and lowers the price target from C$3.7 to C$2.9.

TSX:OGI

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Raymond James Maintains Outperform on Telefonaktiebolaget L M, Lowers Price Target to $12

By Benzinga Newsdesk
July 15, 4:40 AM
Raymond James analyst Simon Leopold maintains Telefonaktiebolaget L M (NASDAQ:ERIC) with a Outperform and lowers the price target from $14 to $12.

ERIC

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Keybanc Initiates Coverage On PROCEPT BioRobotics with Overweight Rating, Announces Price Target of $47

By Benzinga Newsdesk
July 15, 4:35 AM
Keybanc analyst Matthew Mishan initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight rating and announces Price Target of $47.

PRCT

Read More
1 minute read
  • Analyst Ratings
  • Earnings
  • Movers
  • News
  • Price Target
  • Trading Ideas

10X Genomics Reports Q2 Preliminary Revenues, Shares Plummet On Missing Street Expectation

By Akanksha Bakshi
July 14, 5:00 PM
10X Genomics Inc (NASDAQ:TXG) reported preliminary second-quarter revenue is expected to be ~$114.5 million, a decrease of 1% year-over-year, below the…

TXG

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Deutsche Bank Cuts Delta Air Lines Price Target By ~15%

By Akanksha Bakshi
July 14, 3:43 PM
Deutsche Bank analyst Michael Linenberg lowered the price target on Delta Air Lines, Inc. (NYSE:DAL) to $47 from $55 while maintaining the Buy…

DAL

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Baird Downgrades Industrial Distribution Trio To Neutral Rating

By Akanksha Bakshi
July 14, 3:22 PM
Baird analyst David Manthey downgraded Fastenal Co (NASDAQ:FAST) to Neutral from Outperform, with a price target of $48 (an upside of 1%).…

FAST

Posts pagination

Previous 1 … 2,072 2,073 2,074 … 2,160 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service